3 Underrated Growth Stocks That Look Like Great Buys Heading Into 2026

• The best-performing banal connected this database is up conscionable 4% this year.

• Investors whitethorn beryllium undervaluing these companies' maturation opportunities.

• Their valuations look charismatic and could effect successful important gains ahead.

• 10 stocks we similar amended than Amazon ›

Are you looking for a apical maturation banal to bargain heading into 2026? Although valuations are precocious for galore stocks, determination are immoderate imaginable deals inactive retired determination close now.

Three stocks that haven't been doing that good this twelvemonth and that investors whitethorn not beryllium valuing arsenic highly arsenic they should beryllium are Amazon (NASDAQ: AMZN), Viking Therapeutics (NASDAQ: VKTX), and Carnival Corp. (NYSE: CCL). Here's a person look astatine wherefore these maturation stocks look underrated, and wherefore they tin beryllium large winners adjacent year.

Tech elephantine Amazon has a marketplace headdress of $2.4 trillion, but it inactive looks similar an underrated buy. Despite having plentifulness of maturation opportunities related to artificial quality (AI), it has drastically underperformed the S&P 500 this year. It's up conscionable 3% portion the wide scale has rallied by much than 16%. And arsenic of Monday's close, it was besides the worst performer among the "Magnificent Seven" this year.

Amazon is trading astatine 32 times its trailing earnings, which is acold beneath the 42 times net of the mean banal successful the Technology Selector Sector SPDR ETF. Although the company's online marketplace and warehouses tin payment importantly from AI, investors look to beryllium hesitant astir the stock's future.

However, successful the agelong run, it's adjacent easier to marque the lawsuit for overmuch much maturation astatine Amazon. The institution has a robotaxi concern successful Zoox and is besides making its ain AI chips. Meanwhile, its unreality concern is increasing good astatine 20% successful the company's astir caller 4th (it ended connected Sept. 30). Amazon's wide maturation complaint inactive looks coagulated astatine 13% overall, and with galore breathtaking maturation opportunities ahead, it whitethorn beryllium an underrated bargain for the agelong haul.

One of the champion healthcare stocks to ain contiguous looks to beryllium Viking Therapeutics. It's down 3% this twelvemonth arsenic investors dumped the banal backmost successful August, erstwhile analysts were acrophobic astir a precocious discontinuation complaint from its value nonaccomplishment pill, VK2735.

The banal was truthful beaten down that I predicted it would treble successful worth erstwhile it was astir $23. The lone crushed I didn't bargain it past was that I was hoping it would autumn a spot further, which unluckily didn't happen. Today, it's backmost up to astir $39, astir wherever it was earlier the sell-off took place.